These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3995701)

  • 1. Effects of propranolol on atherogenesis in the cholesterol-fed rabbit.
    Chobanian AV; Brecher P; Chan C
    Circ Res; 1985 May; 56(5):755-62. PubMed ID: 3995701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antihypertensive agents propranolol, metoprolol, nadolol, prazosin, and chlorthalidone on ACAT activity in rabbit and rat aortas and on LCAT activity in human plasma in vitro.
    Bell FP
    J Cardiovasc Pharmacol; 1985; 7(3):437-42. PubMed ID: 2410671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of aorta and pulmonary artery: I. Early cholesterol accumulation and relative susceptibility to atheromatous lesions.
    Schwenke DC
    Circ Res; 1997 Sep; 81(3):338-45. PubMed ID: 9285635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall.
    Matsuo M; Ito F; Konto A; Aketa M; Tomoi M; Shimomura K
    Biochim Biophys Acta; 1995 Dec; 1259(3):254-60. PubMed ID: 8541332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HL-004, the ACAT inhibitor, prevents the progression of atherosclerosis in cholesterol-fed rabbits.
    Asami Y; Yamagishi I; Murakami S; Araki H; Tsuchida K; Higuchi S
    Life Sci; 1998; 62(12):1055-63. PubMed ID: 9519807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced atherogenesis in cholesterol-fed diabetic rabbits. Giant lipoproteins do not enter the arterial wall.
    Nordestgaard BG; Stender S; Kjeldsen K
    Arteriosclerosis; 1988; 8(4):421-8. PubMed ID: 3395278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cholesterol-induced increases in arterial wall permeability by propranolol.
    Sasaki K; LaMorte WW; Nickerson CJ; Fuller RM; Chobanian AV; Menzoian JO
    J Surg Res; 1987 Dec; 43(6):565-70. PubMed ID: 3695457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of F-1394, an acyl-CoA:cholesterol acyltransferase inhibitor, on atherosclerosis induced by high cholesterol diet in rabbits.
    Aragane K; Kojima K; Fujinami K; Kamei J; Kusunoki J
    Atherosclerosis; 2001 Sep; 158(1):139-45. PubMed ID: 11500184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term exposure to high dietary cholesterol in early life: arterial changes and response after normalization of plasma cholesterol.
    Subbiah MT; Sprinkle JD; Rymaszewski Z; Yunker RL
    Am J Clin Nutr; 1989 Jul; 50(1):68-72. PubMed ID: 2750698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTE-122, an acyl-coa:cholesterol acyltransferase inhibitor, prevents the progression of atherogenesis in cholesterol-fed rabbits.
    Azuma Y; Date K; Ohno K; Matsushiro S; Nobuhara Y; Yamada T
    Jpn J Pharmacol; 2001 May; 86(1):120-3. PubMed ID: 11430463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters.
    Nakamura S; Kamiya S; Shirahase H; Kanda M; Yoshimi A; Tarumi T; Kurahashi K
    Arzneimittelforschung; 2004; 54(2):102-8. PubMed ID: 15038459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of aorta and pulmonary artery: II. LDL transport and metabolism correlate with susceptibility to atherosclerosis.
    Schwenke DC
    Circ Res; 1997 Sep; 81(3):346-54. PubMed ID: 9285636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the acyl-CoA:cholesterol acyltransferase inhibitor, E5324, on experimental atherosclerosis in rabbits.
    Tanaka H; Ohtsuka I; Kogushi M; Kimura T; Fujimori T; Saeki T; Hayashi K; Kobayashi H; Yamada T; Hiyoshi H
    Atherosclerosis; 1994 Jun; 107(2):187-201. PubMed ID: 7980693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nifedipine reduces atherogenesis in cholesterol-fed heterozygous WHHL rabbits.
    Atkinson JB; Swift LL
    Atherosclerosis; 1990 Oct; 84(2-3):195-201. PubMed ID: 2282099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal evaluation of fatty acid-binding protein (FABP) activity in association with the development of atherosclerosis in the rabbit.
    St John LC; Bell FP
    Comp Biochem Physiol Comp Physiol; 1992 Jun; 102(2):357-61. PubMed ID: 1354584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased microsomal membrane fluidity in the development of cholesterol-induced atherosclerosis in the rabbit.
    Robinson C; Gillies P
    Exp Mol Pathol; 1986 Dec; 45(3):294-302. PubMed ID: 3792513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of acyl-CoA:cholesterol O-acyltransferase in aortic microsomes from atherosclerotic rabbits.
    Brecher P; Chan CT
    Biochim Biophys Acta; 1980 Mar; 617(3):458-71. PubMed ID: 7370290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activity of cholesterol acyltransferase and cholesterol esterase in liver subcellular fractions of rabbits fed a cholesterol supplemented ration].
    Finagin LK; Miroshnichenko ZN; Zatokovenko VF
    Ukr Biokhim Zh (1978); 1981; 53(4):69-73. PubMed ID: 7281258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No effect of nifedipine on atherogenesis in cholesterol-fed rabbits.
    Stender S; Stender I; Nordestgaard B; Kjeldsen K
    Arteriosclerosis; 1984; 4(4):389-94. PubMed ID: 6466196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dietary fat saturation, cholesterol and cholestyramine on acyl-CoA: cholesterol acyltransferase activity in rabbit intestinal microsomes.
    Field FJ; Salome RG
    Biochim Biophys Acta; 1982 Sep; 712(3):557-70. PubMed ID: 7126624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.